AstraZeneca Stock Plagued As Issues Continue To Mount For Covid Vaccine

AstraZeneca Stock Plagued As Issues Continue To Mount For Covid Vaccine
ALLISON GATLIN
·2 min read

AstraZeneca stock dipped Wednesday after European regulators found a possible link between its Covid vaccine and rare cases of blood clots. The EMA affirmed the benefits outweigh the risks.